Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Dow Jones signs two year renewal agreement with Cxense

Oslo, Norway – 15 July 2019 – Cxense ASA (OSE: CXENSE), the AI-powered data management and intelligent personalization company that drives revenue for publishers and brands, today announces that Dow Jones & Company, Inc. (Dow Jones), a global leader in news and business intelligence and owner of The Wall Street Journal, has renewed its agreement with Cxense for two years with an option to extend for a third year.  Since the start of the partnership with Cxense in 2013, Dow Jones has successfully leveraged Cxense technology and know-how to grow digital revenue for its flagship publication,

Cxense ASA: End of quarter recurring revenue update

Oslo, Norway - 15 July 2019 - Cxense ASA (OSE: CXENSE) today announced that it in Q2 2019 signed 16 new contracts with Quarterly Recurring Revenue (QRR) effect of USD 171.7 thousand for the company's data management platform (DMP) with intelligent personalization. Full QRR effect from 17 contracts notified to be terminated in Q2 2019 was USD 190.1 thousand for the core business. As a result, net new QRR from new and lost contracts was USD -18.4 thousand. New QRR Q1 2019 Q2 2019 Change %New QRR from new clients 61.6 131.9 114.1%New QRR

NOTE’s Interim Report January–June 2019

Financial performance April–June• Sales increased by 25% to SEK 437 (351) million. Excluding acquisition, the growth was 13%.• Operating profit up by 30% to SEK 31 (23) million.• Operating margin widened by 0.3 percentage points to 7.0% (6.7%).• Profit after financial items rose to SEK 29 (22) million.• Profit after tax increased by 37% to SEK 23 (17) million, corresponding to SEK 0.81 (0.59) per share.• Cash flow after investments amounted to SEK -24 (-18) million, or SEK -0.82 (-0.62) per share. Financial performance January–June• Sales increased by 28% to SEK 843 (658)

Invitation to conference call, July 22 at 1:00 pm CEST

Studsvik AB presents its Interim Report for the second quarter 2019 and hereby invites media and analysts to a conference call held in English on Monday, July 22 at 1:00 pm CEST.Studsvik’s Interim Report for the second Quarter 2019 will be distributed at approximately 11.00 am CEST, July 22. As of this time, the report will also be available at www.studsvik.com. The call will be held in English, starting 1:00 pm CEST. Please call at least ten minutes prior to the start of the conference call to avoid delay. Event title is: Studsvik Q2 2019. Conference ID is: 4454579  Description

Revenio Group Oyj - Managers' Transactions

15.7.2019 – 9.15 Revenio Group Oyj – Managers' TransactionsPerson subject to the notification requirement Name: Timo Hildén Position: Chief Executive Officer (X) Legal person Issuer: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 743700I27E0FWSXLKK04_20190714211443_2 ____________________________________________ Transaction date: 2019-07-10 Venue: FIRST NORTH FINLAND (FNFI) Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT ISIN: FI4000261045 Nature of the transaction:

Idogen appoints Anders Karlsson as new CEO

Idogen AB (”Idogen”) announces today that Anders Karlsson has been appointed new CEO for the company. He will take up his new position on August 19, 2019. Anders Karlsson has a broad experience from a range of pharma and medtech companies, including leading positions at Novartis and Olerup International. Most recently, Anders Karlsson served as CEO of Allenex AB where he managed the merger with CareDx Inc. In his previous positions, he has successfully re-positioned companies and negotiated global cooperation agreements. ”We are very pleased with the recruitment of Anders Karlsson.

Handelsbanken’s interim report for January-June 2019 will be presented on July 17

Handelsbanken will present its results for January­‑June 2019 in Stockholmon July 17, 2019, at 9:30 a.m. CET, at a meeting with the media and analysts. The interim report for January‑June 2019 will be published at 6:45 a.m. CET,on July 17, 2019. A telephone conference will be held at 10:45 a.m. CET (4:45 a.m. EST), whenRolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 333–300 0804Swedish number: +46 8–566 426 51US number: +1 631–913 1422 PIN code: 23211797# Instructions1.

Balder acquires properties in Stockholm, Helsinki and London

Fastighets AB Balder (publ) in three transactions, has agreed to acquire four properties with a total lettable area of about 28,000 sq.m for approximately SEK 1,600m. The properties in Stockholm and London mainly consist of offices and educational premises and the property in Helsinki is a hotel. All properties are located in the central areas of the capital cities. The property in London was taken into possession during the second quarter, the property in Finland was taken into possession in the third quarter and the Stockholm properties were taken into possession during the fourth quarter.

Isofol Announces Recent Advisory Board Meeting Covering Development Plan for arfolitixorin

GOTHENBURG, Sweden, July 15, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the outcome of an advisory board meeting held to discuss the current status and ongoing strategy for the development of arfolitixorin, the company’s proprietary drug candidate being studied in the global pivotal Phase 3 AGENT study for advanced colorectal cancer. Arfolitixorin has the potential to significantly broaden and optimize the use of chemotherapy regimens containing fluorouracil (5-FU) for the treatment of metastatic colorectal cancer. The meeting, held during the 2019

Q2 Interim Report January - June 2019

In the second quarter Byggmax Group developed positively despite a more cautious market: sales and gross margin increased, cost control remained strong, Byggmax continued to take market share and Skånska Byggvaror increased profitability for the fourth consecutive quarter. Earnings measured as EBITA were in line with last year.Second quarter 2019:   •Net sales increased by 3.9 percent to SEK 1,799.0 M (1,731.2)   •Gross margin increased to 30.7 percent (30.2)   •EBITA excluding non recurring items was in line with the corresponding period last year and totaled SEK 132.9 M (135.3)

Notice of Extraordinary General Meeting of Shareholders in Loomis AB (publ)

The shareholders of Loomis AB, Reg. No 556620-8095, are hereby invited to attend the Extraordinary General Meeting (”EGM”) to be held at 10 a.m. CEST on Wednesday 28 August 2019 in Folkets Hus, Stockholm City Conference Center, entrance Barnhusgatan 12-14, Stockholm. Registration for the EGM begins at 9.30 a.m. CEST.A.                  NOTICE OF ATTENDANCE Shareholders who wish to attend the EGM must: (i) be recorded in the share register maintained by Euroclear Sweden AB, made as of Thursday 22 August 2019, and (ii) notify the company of their intention to participate in the EGM

Update on US regulatory decision for Farxiga

15 July 2019 07:00 BST   Update on US regulatory decision for Farxiga in type-1 diabetes AstraZeneca today announced that the US Food and Drug Administration (FDA) has issued a complete response letter regarding the supplemental New Drug Application for Farxiga(dapagliflozin) as an adjunct treatment to insulin to improve glycaemic control in adult patients with type-1 diabetes (T1D), when insulin alone does not provide adequate glycaemic control. AstraZeneca will work closely with the FDA to discuss the next steps. Farxiga was recently approved in Europe (5mg) and Japan (5mg,

Sinch AB (publ): Invitation to conference call and web presentation of Sinch Q2 2019 interim report

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH Sinch AB will publish its 2019 second quarter interim report on Friday, July 19, 2019, at 07:30 AM CET. You are invited to participate in a conference call at 09:00 AM CET on the same day. Oscar Werner, CEO, and Roshan Saldanha, CFO, will present the report and review the results. Time for publication of the interim reportFriday July 19, 2019, at 07:30 AM CET Time for conference call and web presentationFriday July 19, 2019, at 09:00 AM CET Dial-in numbers and access codePlease make sure you are connected to the phone

Robust profits with improved margin

Inwido’s President and CEO Henrik Hjalmarsson comments on the second quarter and the first six months of 2019:“During the second quarter of 2019, we continued to deliver robust profits with a strengthened margin and improved cash flow, despite a challenging window market in Sweden and Finland. The Danish units and our e-commerce business are delivering good profits and our combined assessment is that we are, on the whole, continuing to gain market shares in the Nordic market.” “Compared with the corresponding period in the preceding year, net sales decreased by 1 percent over the quarter

Interim Report January-June 2019

This information is such that Inwido AB (publ) is obliged to publish in accordance with the EU market abuse regulation and the Swedish Securities Market Act. The information was submitted by the below contact persons for publication on 15 July 2019 at 7:45 a.m. CET. Robust earnings with strengthened margin April – June 2019 · Net sales amounted to SEK 1,710 million (1,729), representing a decrease of 1 percent. Organic growth was a negative 4 percent. · EBITA amounted to SEK 187 million and the EBITA margin increased to 10.9 percent. EBITA amounted to SEK 184 million (184) and

Share buy-backs in Telia Company during week 28 2019

During the period July 8, 2019, until July 12, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,629,671 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back program that Telia Company announced on April 16, 2019. The share buy-back program, which runs between April 16, 2019, and February 28, 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period July 8,

Interim report January – June 2019

JANUARY – JUNE 2019 · Income, MSEK 656 (486) · Profit after tax, MSEK 470 (655) · Profit after tax per share, 2.80 SEK (3.90) APRIL – JUNE 2019 · Income, MSEK 333 (239) · Profit after tax, MSEK 309 (396) · Profit after tax per share, 1.84 SEK (2.36) SIGNIFICANT EVENTS DURING AND AFTER THE QUARTER · In May, three-year senior unsecured bonds of MSEK 750 within a total framework amount of up to SEK 1.5 billion were issued. · In June, a property portfolio with 21 properties in southern Sweden was acquired for a value of SEK 1.6 billion. · In June, Nyfosa’s

Clas Ohlson´s sales in June remain strong

Clas Ohlson’s sales in June are unchanged compared with June last year when excluding the calendar effect due to lower number of trading days than in the year-earlier period. Sales in June also meet extraordinary comparative figures from Clas Ohlson's 100th anniversary and campaign in June last year. For the first two months of the financial year 2019/20 (May and June), sales increase by 1 percent, corresponding to unchanged organic sales.June sales decrease by 3 per cent to 676 MSEK (697). In June, sales are negatively impacted by a calendar effect of approximately 3 percentage points due

High growth and good profitability

The second quarter of the year was favourably affected mainly by Willys’ continued strong performance as well as by Axfood Snabbgross’s profitable growth. We continue to take market shares and delivered better earnings than last year. We did this at the same time that we are making a number of future-oriented investments in the store network, e-commerce and logistics solutions for the future.President and CEO Klas Balkow’s comments on the interim report for the second quarter 2019: “Our sales growth of 6.7% is proof that our various food concepts are consolidating already strong

Targovax announces start of the expansion part in the phase I/II trial with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies

Oslo, Norway, 15 July 2019: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces the start of the expansion part in the phase I/II trial with ONCOS-102 in combination with durvalumab. All safety reviews during the dose escalation phase have been completed with no Dose Limiting Toxicities (DLT) reported and the five US hospital sites are now open for further recruitment. This phase I/II trial investigates the safety, biologic and anti-tumor activity of ONCOS-102 in

Lantmännen’s harvest forecast: This year’s harvest − better than the 5-year average

This year’s grain harvest is set to be good, an absolute necessity for many farmers who were hit hard by last year’s heat and drought. According to the Lantmännen forecast, the Swedish harvest of grain, oilseed crops and pulses will exceed the 5-year average.Lantmännen’s forecast for grain, oilseed crops and pulses amounts to 6.3 million tons for the 2019 harvest. This estimate is 75 percent higher than last year’s extraordinarily low harvest of 3.6 million tons. “A good grain harvest this year is of utmost importance for Lantmännen members, Swedish farmers, bearing in mind the poor

Read original

Africa Energy Announces Signing of Rig Contract for Block 11B/12B

July 15, 2019 – Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, is pleased to announce that the joint venture partnership for Block 11B/12B offshore South Africa has entered into a multi-well drilling contract with Odfjell Drilling for the Deepsea Stavanger semi-submersible rig. Garrett Soden, Africa Energy’s President and CEO, commented, “We are very pleased that Total was able to secure the Deepsea Stavanger rig again for the next phase of drilling on

RaySearch and Vision RT announce strategic partnership

RaySearch and Vision RT, two of the leading companies in the radiation oncology space, today announced a strategic partnership, to work together on technology development projects.While details of these developments are currently confidential, both companies’ intention is to deliver both improved integration and entirely new capabilities to radiation oncology professionals, to help enhance workflow and improve clinical decision-making. Vision RT and RaySearch make natural partners as their activities are very complementary, while they are both highly focused on innovative customers

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Hawaii

Free youth baseball clinic to feature Fernando Vina, Hawaii native MLB players and other AlumniColorado Springs, Colo. – Hawaiian youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series. In partnership with Chevy Youth Baseball , the free clinics will feature National League All-Star and two-time Gold Glove Award winner Fernando Vina and Hawaii natives Kila Ka’aihue, Onan Masaoka and Tyler Yates, as well as Rene Gonzales, Ron Robinson

There are no items matching the current filter
There are no more items matching the current filter
Back to top